NCT03159702 · OUTCOME

Acute Graft-versus-host Disease (GVHD) at Day 100 and 180.

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation · Source last updated 2026-01-27

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Days 100 and 180

What was measured

The number of participants with graft-versus-host disease using the Center for International Bone Marrow Transplant Research criteria.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: The number of participants with graft-versus-host disease using the Center for International Bone Marrow Transplant Research criteria.
reporting Status: NOT_POSTED
time Frame: Days 100 and 180
title: Acute Graft-versus-host Disease (GVHD) at Day 100 and 180.
type: SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice